Doctors 2.0 & You and Expanscience Introduce New Preventive Health Short Video Awards Contest

Doctors 2.0 & You4 - 5 June 2015, Paris, France.
United by their mutual commitment to the preservation of health in people everywhere, Doctors 2.0 & You, the international digital health conference and industry partner, Expanscience, an international pharmaceutical and dermo-cosmetics laboratory, invite videomakers to contribute to health prevention promotion by participating in the First Health Prevention Short Video Contest Awards.

Applicants to the contest are invited to produce a short video (up to 120 seconds) that expresses public health messages on one of the two following themes that will benefit from the expertise of Expanscience.

  • How to preserve skin health in babies, teens, pregnant women, and new moms
  • How to prevent osteoarthritis and other rheumatological diseases

According to Doctors 2.0 & You founder Denise Silber, "A short video is an excellent medium to reach and impact a broad audience. We are very pleased to join forces with Expanscience to encourage the production and distribution of great videos and hope that many people will be inspired to help out."

For Jean-Paul Berthomé, CEO of Expanscience, "A brand has more than one dimension and a company as well. At Expanscience we are not just in the business of pharmaceuticals and dermo-cosmetics. Health and prevention are a priority for us. So, it was very natural for us to enter into partnership with Doctors 2.0 & You and reward two video projects, one in the prevention of osteoarthritis and related conditions and the other for the maintenance of healthy skin. We truly hope people around the world will contribute their ideas."

About the Awards Process

  • Contest submissions are open from April 14th, 2015 to May 19th, 2015.
  • The first prize winner in each category (skin health and rheumatology) will receive an award of 2000 euros.
  • The decision will be made by a jury of 7 persons selected for their experience in healthcare and communication.
  • The winner will be announced during the 5th Edition of Doctors 2.0 & You, on June 5, 2015 at Cité Universitaire Paris, France.
  • Videos that respond to the criteria indicated in the complete contest rules online will be displayed on the Doctors 2.0 & You Facebook page during the contest period and through October 31, 2015. The winning videos will be promoted online more broadly.
  • To apply, contestants must fill in the form on the website and submit their video online at http://www.doctors20.com/contests-2/short-video-contest-2015/

For further information, please visit:
http://www.doctors20.com

About Doctors 2.0 & You
Innovative, Insightful, Inspiring, Doctors 2.0 & You is "the must-attend annual digital health conference in Europe". Taking place in Paris, for its fifth edition, on June 4-5, 2015, Doctors 2.0 & You is the only international congress providing a 360° view of state of the art tools and services linking patients and physicians with all other healthcare stakeholders. The conference was founded by Denise Silber, pioneering digital health strategist and influencer.and president of Basil Strategies.

Attendees include patients, professionals, healthcare industries, technologists, payers, government. Key topics in 2015 will include artificial intelligence, augmented reality, 3d printing, connected objects as well as mobile apps, communities, serious games, with examples of deployment in multiple medical conditions. The hashtag #doctors20 is the most tweeted in its category, with nearly 9000 participants to-date.

About Expanscience
In 2014, Expanscience - a French independently-owned pharmaceutical and dermo-cosmetics laboratory - generated turnover of €269.8 million, 46.1% of which was through exports, and employed 967 people. Over more than 60 years, the company has built up a solid international reputation as an innovator and as a specialist in skin and the treatment of arthritis. Its products, which include two leading brands - Piasclédine 300 and Mustela - are sold in more than 97 countries (84 distributing countries and 13 subsidiaries). Expanscience develops and also sells natural-origin active ingredients for use in cosmetics, both in France and abroad. The whole value chain is integrated into the company - from research through to production and distribution. Its CSR policy, which was introduced 10 years ago, was recognised as exemplary by the AFAQ 26000 assessment in 2013.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...